The study of pancreatic cancer PSN-1 cells indicated that the knockdown of SRP72 resulted in a significant increase in sensitization to radiation therapy as measured by colony formation assays, indicating that SRP72 is a marker of radiotherapy resistance against cancer (22). Here, SRP72 is linked to familial pancreatic carcinoma.